2003 Pharmacy Regulations Vaccine 
Drug & Device Law
FEBRUARY 20, 2023
For several decades – starting with plaintiffs’ pre-Vaccine Act attacks on vaccine designs – courts have addressed FDA approval as a component of “feasibility” in states that impose this limitation on design defect claims. Or does it suffice that a vaccine design has been approved in other countries? In Bruesewitz v.
Drug & Device Law
JANUARY 4, 2024
The complaint, brought under the Texas consumer protection statute, sued a major manufacturer of COVID-19 vaccine that was used to control the recent pandemic. 2003); Birdsong v. Today’s milestone puts us one step closer to altering the course of this pandemic in the U.S.” FDA (8/23/21) press release (emphasis original). 523, 529 (S.D.
Expert insights. Personalized for you.
59 
Let's personalize your content